Value 4 Growth

FlandersBio on Twitter

Biotech company Ablynx wins European Mediscience Award: http://tiny.cc/knen6

posted 1 month ago

Social Media

Life Sciences Database

in het nederlands

FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.

Website: http://www.v4g.be
Email:
Phone: +32 473 96 04 08
FlandersBio Member
More address details

Business Focus

V4G provides a single point of contact to growing your company. V4G is a totally independent group.

Company Profile

V4G has a hands-on approach tailored to the specific needs of its clients.
V4G's team has complementary technical skills (biotech and ICT) and operational skills in areas as diverse as general management, R&D, business development, finance and intellectual property (IP) management.
As proof of our commitment and our willingness to share risk, V4G may propose a variable remuneration based partially on an equity participation. V4G also acts as a business angel investor in selected start-ups and early-stage companies.

V4G focuses on coaching profitable growth for its clients, covering all management aspects of growth, whether

internal, by maximizing overall operations, business strategies, financing, strategic alliances and technology platform optimization, or
external, through mergers and acquisitions.

Science & Technology or Services

Business and strategic planning/ Fund raising: write-up of business plans and private placement memorandi, prioritize business models and assist in the implementation.
Intellectual Property management: strategic evaluation of patent portfolio's, recommendation and implementation of worldwide patent strategies, drafting of patent applications, prosecution follow-up.
International business development: through our industrial, academic and financial network, we identify partners for strategic, technological and/or commercial alliances, negotiate "a la carte" license agreements and term sheets.
Due-diligence work for investors, especially from a strategic, IP and technological point of view.

Some recent assignments:

for a drug delivery company, define the R&D strategy and coordinate the business development activities;
for a therapeutics company, define the IP strategy and manage the patent portfolio;
for a diagnostics company, develop a strategic plan, draft the private placement memorandum and coordinate the fund raising;
for an OTC company, prioritize the product development activities and develop a marketing strategy;
for several European venture capitalists, provide due diligence analyses of the technology, product portfolio and IP portfolio;
for a spin-off of a multinational, draft the private placement memorandum and coordinate the fund raising.